BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 35664779)

  • 1. Corrigendum: Upregulation of CCT-3 Induces Breast Cancer Cell Proliferation Through miR-223 Competition and Wnt/b-Catenin Signaling Pathway Activation.
    Qu H; Zhu F; Dong H; Hu X; Han M
    Front Oncol; 2022; 12():917378. PubMed ID: 35664779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Upregulation of CCT-3 Induces Breast Cancer Cell Proliferation Through miR-223 Competition and Wnt/β-Catenin Signaling Pathway Activation.
    Qu H; Zhu F; Dong H; Hu X; Han M
    Front Oncol; 2020; 10():533176. PubMed ID: 33072568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-1229 overexpression promotes cell proliferation and tumorigenicity and activates Wnt/β-catenin signaling in breast cancer.
    Tan Z; Zheng H; Liu X; Zhang W; Zhu J; Wu G; Cao L; Song J; Wu S; Song L; Li J
    Oncotarget; 2016 Apr; 7(17):24076-87. PubMed ID: 26992223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MiR-454-3p-Mediated Wnt/β-catenin Signaling Antagonists Suppression Promotes Breast Cancer Metastasis.
    Ren L; Chen H; Song J; Chen X; Lin C; Zhang X; Hou N; Pan J; Zhou Z; Wang L; Huang D; Yang J; Liang Y; Li J; Huang H; Jiang L
    Theranostics; 2019; 9(2):449-465. PubMed ID: 30809286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Corrigendum: Ubiquitin C-Terminal hydrolase L5 (UCHL5) accelerates the growth of endometrial cancer
    Liu D; Song Z; Wang X; Ouyang L
    Front Oncol; 2022; 12():992496. PubMed ID: 36059647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo and in vitro effects of microRNA-27a on proliferation, migration and invasion of breast cancer cells through targeting of SFRP1 gene via Wnt/β-catenin signaling pathway.
    Kong LY; Xue M; Zhang QC; Su CF
    Oncotarget; 2017 Feb; 8(9):15507-15519. PubMed ID: 28099945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiR-34a Inhibits Breast Cancer Proliferation and Progression by Targeting Wnt1 in Wnt/β-Catenin Signaling Pathway.
    Si W; Li Y; Shao H; Hu R; Wang W; Zhang K; Yang Q
    Am J Med Sci; 2016 Aug; 352(2):191-9. PubMed ID: 27524218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-590-5p functions as a tumor suppressor in breast cancer conferring inhibitory effects on cell migration, invasion, and epithelial-mesenchymal transition by downregulating the Wnt-β-catenin signaling pathway.
    Gao J; Yu SR; Yuan Y; Zhang LL; Lu JW; Feng JF; Hu SN
    J Cell Physiol; 2019 Feb; 234(2):1827-1841. PubMed ID: 30191949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Upregulation of miR-199a/b contributes to cisplatin resistance via Wnt/β-catenin-ABCG2 signaling pathway in ALDHA1
    Chen B; Zhang D; Kuai J; Cheng M; Fang X; Li G
    Tumour Biol; 2017 Jun; 39(6):1010428317715155. PubMed ID: 28639895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-449b-5p suppresses the growth and invasion of breast cancer cells via inhibiting CREPT-mediated Wnt/β-catenin signaling.
    Jiang J; Yang X; He X; Ma W; Wang J; Zhou Q; Li M; Yu S
    Chem Biol Interact; 2019 Apr; 302():74-82. PubMed ID: 30738779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MiR-214 negatively regulates proliferation and WNT/β-catenin signaling in breast cancer.
    Yi SJ; Li LL; Tu WB
    Eur Rev Med Pharmacol Sci; 2016 Dec; 20(24):5148-5154. PubMed ID: 28051254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Upregulation of miR-543-3p promotes growth and stem cell-like phenotype in bladder cancer by activating the Wnt/β-catenin signaling pathway.
    Gao RL; Chen XR; Li YN; Yan XY; Sun JG; He QL; Cai FZ
    Int J Clin Exp Pathol; 2017; 10(9):9418-9426. PubMed ID: 31966814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SOX30, a target gene of miR-653-5p, represses the proliferation and invasion of prostate cancer cells through inhibition of Wnt/β-catenin signaling.
    Fu Q; Sun Z; Yang F; Mao T; Gao Y; Wang H
    Cell Mol Biol Lett; 2019; 24():71. PubMed ID: 31889959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Promoting effects of MiR-135b on human multiple myeloma cells via regulation of the Wnt/β-catenin/Versican signaling pathway.
    Chen H; Zhao Y; Zhang J; Xie Y; Jin M
    Cytokine; 2021 Jun; 142():155495. PubMed ID: 33765653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LGR5 acts as a target of miR-340-5p in the suppression of cell progression and drug resistance in breast cancer via Wnt/β-catenin pathway.
    Shi S; Chen X; Liu H; Yu K; Bao Y; Chai J; Gao H; Zou L
    Gene; 2019 Jan; 683():47-53. PubMed ID: 30300682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Corrigendum: Long Noncoding RNA NONHSAT079852.2 Contributes to GBM Recurrence by Functioning as a ceRNA for has-mir-10401-3p to Facilitate HSPA1A Upregulation.
    Zhao N; Zhang J; Zhao L; Fu X; Zhao Q; Chao M; Cao H; Jiao Y; Hu Y; Chen C; Wang L; Wang H
    Front Oncol; 2021; 11():807421. PubMed ID: 34950595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-100 suppresses the migration and invasion of breast cancer cells by targeting FZD-8 and inhibiting Wnt/β-catenin signaling pathway.
    Jiang Q; He M; Guan S; Ma M; Wu H; Yu Z; Jiang L; Wang Y; Zong X; Jin F; Wei M
    Tumour Biol; 2016 Apr; 37(4):5001-11. PubMed ID: 26537584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Mechanism of miR-155 Promoting Drug Resistance in Childhood Acute Lymphoblastic Leukemia by Regulating Wnt/β-Catenin Signaling Pathway].
    Huang HM; Wei YJ; Wang D; Wen XM
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Apr; 30(2):418-424. PubMed ID: 35395973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-224 inhibits proliferation and migration of breast cancer cells by down-regulating Fizzled 5 expression.
    Liu F; Liu Y; Shen J; Zhang G; Han J
    Oncotarget; 2016 Aug; 7(31):49130-49142. PubMed ID: 27323393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MiR-452 promotes an aggressive colorectal cancer phenotype by regulating a Wnt/β-catenin positive feedback loop.
    Li T; Jian X; He H; Lai Q; Li X; Deng D; Liu T; Zhu J; Jiao H; Ye Y; Wang S; Yang M; Zheng L; Zhou W; Ding Y
    J Exp Clin Cancer Res; 2018 Sep; 37(1):238. PubMed ID: 30253791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.